Phleum pratense pollen allergy immunotherapy (HAL Allergy)

N/A

Report date: 2022/07/19 20:00:45

Base Information

Drug NamePhleum pratense pollen allergy immunotherapy (HAL Allergy)
Drug Alias NameSUBLIVAC FIX Phleum pratenseSublivac Fix Phleum pratenseSublivac Fix Grasses
ClassificationBiologics > Antigen > Allergen extract
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsConjunctivitis, AllergicRhinitis, Allergic, Seasonal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumPolandNetherlands +[4] 
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesHal Allergy
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHal Allergy
Active IndicationsN/A
Inactive IndicationsConjunctivitis, AllergicRhinitis, Allergic, Seasonal

Other Information

ATC CodeN/A
Related LinksN/A